Küçükyurt Kaya, S. et al. (2026) “Comparative prognostic performance of ELN 2022 and ELN 2024 risk classifications in a Turkish cohort of acute myeloid leukemia patients receiving hypomethylating agents and BCL-2 inhibitors”, Acta Medica, 57(2), pp. 157–165. doi:10.32552/actamedica.2026.1271.